載入...
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia
Given their recognized ability to kill acute myeloid leukemia (AML) blasts both in vitro and in vivo, Vγ9Vδ2 T cells are of growing interest in the design of new strategies of immunotherapy. We show that the Butyrophilin3A (BTN3A, CD277) subfamily is a critical determinant of Vγ9Vδ2 TCR-mediated rec...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5087298/ https://ncbi.nlm.nih.gov/pubmed/27853633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1146843 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|